ask="48.50"
ask_size="200"
average_daily_volume="1121090"
bid="N/A"
bid_size="N/A"
book_value="10.71"
change="+0.37"
change_from_200_day_moving_average="-3.99"
change_from_50_day_moving_average="4.42"
change_from_52_week_high="-33.49"
change_From_52_week_low="15.24"
change_in_percent="+0.80%"
close="46.62"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.09"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.74"
ex_dividend_date="N/A"
float_shares="71075000"
high="47.15"
high_52_weeks="80.11"
last_trade_date="2/24/2017"
last_trade_price="46.62"
last_trade_size="16519"
last_trade_time="4:00pm"
low="45.00"
low_52_weeks="31.38"
market_capitalization="4.01B"
moving_average_200_day="50.61"
moving_average_50_day="42.20"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="45.90"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="-7.88%"
percent_change_from_50_day_moving_average="+10.48%"
percent_change_from_52_week_high="-41.81%"
percent_change_from_52_week_low="+48.57%"
previous_close="46.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.32"
price_per_sales="84.36"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.08"
stock_exchange="NMS"
symbol="ALNY"
volume="642690"
weeks_range_52="31.38 - 80.11"
